lucanthone hydrochloride has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carew, JS; Espitia, CM; Esquivel, JA; Giles, FJ; Kelly, KR; Mahalingam, D; Nawrocki, ST; Reddy, G | 1 |
1 other study(ies) available for lucanthone hydrochloride and Breast Cancer
Article | Year |
---|---|
Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cathepsin D; Cell Line, Tumor; Drug Synergism; Gene Expression Profiling; Humans; Hydroxamic Acids; Intracellular Membranes; Lucanthone; Lysosomes; Microtubule-Associated Proteins; Oligonucleotide Array Sequence Analysis; Permeability; Phagosomes; Reverse Transcriptase Polymerase Chain Reaction; Schistosomicides; Sequestosome-1 Protein; Tumor Suppressor Protein p53; Vorinostat | 2011 |